Kevin Holden

3.9k total citations · 1 hit paper
8 papers, 872 citations indexed

About

Kevin Holden is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kevin Holden has authored 8 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Epidemiology. Recurrent topics in Kevin Holden's work include CRISPR and Genetic Engineering (6 papers), RNA regulation and disease (2 papers) and RNA and protein synthesis mechanisms (2 papers). Kevin Holden is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), RNA regulation and disease (2 papers) and RNA and protein synthesis mechanisms (2 papers). Kevin Holden collaborates with scholars based in United States and Spain. Kevin Holden's co-authors include Jennifer Oki, Reed Kelso, Brittany L. Enzmann, Travis J. Maures, David S. Conant, Nicholas A. Rossi, Joyce Yang, Jared Carlson-Stevermer, Jennifer M. Hayashi and Keith Walcott and has published in prestigious journals such as Cell, Nature Communications and Nature Biotechnology.

In The Last Decade

Kevin Holden

8 papers receiving 861 citations

Hit Papers

Inference of CRISPR Edits... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Holden United States 7 578 198 134 130 99 8 872
Heike Kollmus Germany 18 548 0.9× 125 0.6× 83 0.6× 160 1.2× 159 1.6× 31 1.0k
Klara Höning Germany 9 523 0.9× 105 0.5× 112 0.8× 356 2.7× 103 1.0× 10 837
Shivani K Thaker United States 4 266 0.5× 174 0.9× 119 0.9× 135 1.0× 128 1.3× 5 617
Yafeng Zhu China 16 642 1.1× 67 0.3× 127 0.9× 93 0.7× 72 0.7× 28 1.0k
Nishi Sharma United States 15 359 0.6× 125 0.6× 49 0.4× 143 1.1× 172 1.7× 24 702
Hugo Würtele Canada 18 1.2k 2.0× 110 0.6× 131 1.0× 62 0.5× 130 1.3× 40 1.4k
Urszula Jankowska Poland 16 526 0.9× 78 0.4× 70 0.5× 84 0.6× 59 0.6× 52 843
Elena Chiavacci Italy 12 508 0.9× 177 0.9× 69 0.5× 70 0.5× 54 0.5× 18 805
Annabel Borg United Kingdom 12 528 0.9× 268 1.4× 42 0.3× 197 1.5× 71 0.7× 13 874
Stephanie Meyer United States 15 365 0.6× 91 0.5× 141 1.1× 60 0.5× 134 1.4× 19 844

Countries citing papers authored by Kevin Holden

Since Specialization
Citations

This map shows the geographic impact of Kevin Holden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Holden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Holden more than expected).

Fields of papers citing papers by Kevin Holden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Holden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Holden. The network helps show where Kevin Holden may publish in the future.

Co-authorship network of co-authors of Kevin Holden

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Holden. A scholar is included among the top collaborators of Kevin Holden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Holden. Kevin Holden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Moreno-Sánchez, Ismael, Pedro Manuel Martínez‐García, Anthony J. Treichel, et al.. (2025). Enhanced RNA-targeting CRISPR-Cas technology in zebrafish. Nature Communications. 16(1). 2591–2591. 3 indexed citations
2.
Katti, Alyna, Miguel Foronda, J. Lynn Zimmerman, et al.. (2023). Generation of precision preclinical cancer models using regulated in vivo base editing. Nature Biotechnology. 42(3). 437–447. 21 indexed citations
3.
Conant, David S., Nicholas A. Rossi, Jennifer Oki, et al.. (2022). Inference of CRISPR Edits from Sanger Trace Data. The CRISPR Journal. 5(1). 123–130. 353 indexed citations breakdown →
4.
Méndez‐Mancilla, Alejandro, Hans‐Hermann Wessels, Mateusz Legut, et al.. (2021). Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells. Cell chemical biology. 29(2). 321–327.e4. 39 indexed citations
5.
Gao, Pan, Qing Lyu, Cícera R. Lazzarotto, et al.. (2021). Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression. Genome biology. 22(1). 83–83. 71 indexed citations
6.
Williams, Caroline G., Alexander S. Jureka, Jesus A. Silvas, et al.. (2021). Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication. Cell Reports. 36(5). 109479–109479. 77 indexed citations
7.
Wang, Ruofan, Camille R. Simoneau, Jessie Kulsuptrakul, et al.. (2020). Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Cell. 184(1). 106–119.e14. 260 indexed citations
8.
Thomas, Russell S., Sharron G. Penn, Kevin Holden, Christopher A. Bradfield, & David R. Rank. (2002). Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics. 12(2). 151–163. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026